Home › Funds › Prudential Financial › BEAM
Prudential Financial position in BEAM
BEAM THERAPEUTICS INC · Health Care
Latest position (Q2 2026)16.36K sh
Reported value held$561.48K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 4.20K | $365.00K | New |
| Q4 2021 | 3.88K | $309.00K | Reduce |
| Q1 2022 | 3.90K | $224.00K | Add |
| Q3 2024 | 14.09K | $345.18K | New |
| Q2 2025 | 11.85K | $244.92K | New |
| Q3 2025 | 11.89K | $288.57K | Hold |
| Q1 2026 | 14.93K | $355.66K | New |
| Q2 2026 | 16.36K | $561.48K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BEAM
- Fidelity Management & Research (FMR) 12.61M sh · $432.74M · Q2 2026
- Farallon Capital Management 10.24M sh · $351.31M · Q2 2026
- ARK Invest 10.23M sh · $351.26M · Q2 2026
- BlackRock Inc 9.00M sh · $308.80M · Q2 2026
- Vanguard Group 9.19M sh · $254.84M · Q4 2025
- Geode Capital Management 2.60M sh · $89.14M · Q2 2026
- Morgan Stanley 1.95M sh · $66.96M · Q2 2026
- Two Sigma Investments 1.39M sh · $47.64M · Q2 2026
- Casdin Capital 1.35M sh · $46.33M · Q2 2026
- Goldman Sachs Group 1.31M sh · $44.96M · Q2 2026
- Northern Trust Corp 933.48K sh · $32.04M · Q2 2026
- Charles Schwab Investment Management 885.90K sh · $30.40M · Q2 2026